Sandro Feriozzi
Rome, 00128, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Immunogenicity in Fabry Disease: Current Issues, Coping Strategies, and Future Directions.
Journal: Biomedicines
Published: December 22, 2025
The role of renal denervation for the treatment of hypertension in patients with chronic kidney disease: a position paper of the Italian Society of Nephrology.
Journal: Journal of nephrology
Published: May 28, 2025
Clinical Efficacy and Real-World Effectiveness of Fabry Disease Treatments: A Systematic Literature Review.
Journal: Journal of clinical medicine
Published: May 23, 2025
Pathogenesis of Organ Damage in Fabry Disease: The AGALopathy Pathogenetic Pathway.
Journal: Journal of the American Society of Nephrology : JASN
Published: January 31, 2025
The Inflammatory Pathogenetic Pathways of Fabry Nephropathy and Agalopathy: GLA Variant Induction of Endoplasmic Reticulum Stress.
Journal: Nephron
Published: November 29, 2024
The safety of corticosteroid therapy in IGA nephropathy: analysis of a real-life Italian cohort.
Journal: Journal of nephrology
Published: May 01, 2024
Natural History and Clinicopathological Associations of TRPC6-Associated Podocytopathy.
Journal: Journal of the American Society of Nephrology : JASN
Published: April 01, 2024
The role of tubular cells in the pathogenesis of Fabry nephropathy.
Journal: Frontiers in cardiovascular medicine
Published: February 14, 2024
Updated Evaluation of Agalsidase Alfa Enzyme Replacement Therapy for Patients with Fabry Disease: Insights from Real-World Data.
Journal: Drug design, development and therapy
Published: December 08, 2023
Pathogenic pathways of renal damage in Fabry nephropathy: interplay between immune cell infiltration, apoptosis and fibrosis.
Journal: Journal of nephrology
Published: October 05, 2023
Cinacalcet in focal segmental glomerular sclerosis: a case report.
Journal: Kidney international
Published: August 10, 2023
Drug utilization in patients starting haemodialysis with a focus on cardiovascular and antidiabetic medications: an epidemiological study in the Lazio region (Italy), 2016-2020.
Journal: BMC nephrology
Published: July 26, 2023
Last Updated: 09/26/2026